Related to this topic: Leaflets | Support | Patient+ | UK Guidelines | News | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Cerebral Palsy

This can best be described as a syndrome in which there is a non-progressive impairment of movement and posture relating to a defect or lesion in the brain.

Various systems of classification exist1:

Classification based on type of movement disorder

  • Spastic - the predominant feature is muscle spasticity.
  • Athetoid - this refers to the involuntary sinuous movements seen in some patients.
  • Ataxic - the main features are balance problems, hand tremor, and speech difficulties.
  • Mixed - there may be a combination of several forms.

Classification based on body part:

  • Hemiplegic
  • Diplegic (upper or lower limbs)
  • Quadriplegic

Gross Motor Function Classification System (GMFCS)

This is an attempt to standardise the assessment of motor function in cerebral palsy patients. It has been modified and enhanced since its introduction in 1997, but it is basically a five-level system assessing the patient's daily motor function. The system may be used as a classification tool and an assessment of responsiveness to treatment.2,3

Gross Motor Function Classification System (GMFCS)

Level I: Walks without restrictions; limitations in more advanced gross motor skills.
Level II: Walks without devices; limitations in walking outdoors and in the community.
Level III: Walks with mobility devices; limitations in walking outdoors and in the community.
Level IV: Self mobility with limitations; children are transported or use power mobility outdoors and in the community.
Level V: Self mobility is severely limited even with the use of supporting technology

Epidemiology

Cerebral palsy is a relatively rare condition. Pooled data from five active cerebral palsy registers in the UK suggest a mean annual prevalence rate of 2.0 per 1000 live births for birth years 1986-1996. Where type is recorded, 91 per cent had spastic cerebral palsy. Where data are available, nearly one-third of children had severely impaired lower limb function, and nearly a quarter had severely impaired upper limb function.4

Risk factors

The incidence is higher in premature infants and twin births.5 Other risk factors include maternal age greater than 35, black race, and intrauterine growth restriction.6

Presentation5

Cerebral palsy may be suspected when delayed milestones are observed (e.g.reaching for toys at 3-4 months, sitting at 6-7 months, and walking at 10-14 months).1 A definitive diagnosis may be difficult until specific signs of cerebral palsy appear, and this may not happen until the child is 12-18 months old. Abnormalities of posture and movement are common throughout the different types of cerebral palsy.
Other presenting features will depend on the type of cerebral palsy, i.e:

  • Spastic type - there may be intermittent increased tone and pathological reflexes (e.g. Babinski response - upward pointing of the big toe on stroking the sole of the foot from the heel to the base of the toe).
  • Athetoid - this is characterised by increased activity (hyperkinesia). This has been described as 'stormy movement.'
  • Ataxic type - there may be loss of orderly muscular coordination so that movements are performed with abnormal force, rhythm, or accuracy.
Differential Diagnosis

The list of differential diagnoses may be wide ranging, and can include normal recovery from perinatal hypoxia, transient dystonia, mental retardation, and a plethora of metabolic and genetic diseases.7The following list are commonly considered in the differential diagnosis of cerebral palsy8:

  • Acute Poliomyelitis
  • Becker Muscular Dystrophy (a group of genetic diseases causing muscle weakness, affects only males9)
  • Charcot-Marie-Tooth Disease
  • Kugelberg Welander Spinal Muscular Atrophy - a rare inherited disorder causing progressive degeneration of the anterior horn cells of the spinal cord.10
  • Neonatal Brachial Plexus Palsies
  • Stroke Motor Impairment
  • Traumatic Brain Injury
Investigations

The type investigations will depend upon the presentation and the list of differential diagnoses that need to be excluded.
A suggested protocol is as follows:7,8

Laboratory Investigations

  • Thyroid studies.
  • Lactate and pyruvate levels to exclude mitochondrial cytopathies (a group of systemic diseases caused by inherited or acquired damage to the mitochondria.11
  • Organic and amino acid levels - to exclude organic acid and amino acid conditions presenting with neurological symptoms.12
  • Chromosome analysis.
  • Cerebrospinal fluid - protein, lactate and pyruvate levels may be helpful in determining whether there has been any asphyxia in the neonatal period.

Neuroimaging studies

Although there are no definitive diagnostic tests, neuroimaging can help to identify patients who are likely to be at risk.

  • Ultrasound can help to identify very preterm babies at risk of cerebral palsy. One study found a strong link between severe cranial abnormalities identified in the neonatal period, and the incidence of cerebral palsy 2 years later, although one third of children with cerebral palsy had no detectable ultrasound abnormalities.13
  • MRI scans are useful for detecting white matter lesions in older children, but traditional methods used in younger children have failed to provide good predictive results.14 However, newer developments and the use of sequential MRI has proven of value in demonstrating the various injuries (e.g. asphyxia) and anomalies that can lead to cerebral palsy. Fetal MRI has also yielded useful information.15
  • CT may provide information about structural congenital malformations and vascular abnormalities and haemorrhages, especially in babies.8

Other Tests

  • Evoked potentials - these are the electric signals produced by the nervous system in response to sensory stimuli. Measuring them can help to detect abnormalities of hearing and vision.16
  • EEG - this can help to detect damage from hypoxia and vascular insult.
Associated Diseases1,8
  • Intrauterine infections - e.g. rubella, HIV, cytomegalovirus, toxoplasmosis.
  • Congenital malformations - this is often due to intrauterine events such as vascular insult, and particularly affects the cerebellum, periventricular regions and corpus callosum.17
  • Toxic or teratogenic agents - including alcohol, cocaine, and cigarette smoke (probably relates to low birth weight).
  • Maternal abdominal trauma - very rare unless there is extensive injury causing co-existent fetal brain trauma.
  • Maternal illness - e.g. intrauterine infections, thyroid abnormalities, and any condition leading to low birth weight.17
  • Intracranial haemorrhage
  • Trauma
  • Infection
  • Hyperbilirubinemia
  • Hypoxia - the role of hypoxia peri-natally is not clearly understood and is now thought to play less of a part than it once did.1
  • Maternal iodine deficiency
  • Seizures
Staging

There is no formal staging method as such but the GMFCS is a useful method of assessing severity. It can be applied to younger age groups, but is most suitable for children aged 6-12.

Management

The treatment of cerebral palsy needs to be multidisciplinary and goal-directed. There is a danger that various abnormalities (e.g. movement disorder) are treated in a jigsaw fashion without any overall view of the benefits to the patient and the family. The GMFCS is a useful guide as to the effectiveness of any particular treatment.
Many disciplines will need to be involved and treatment will often involve input from8:

  • Physiotherapists
  • Occupational Therapists
  • Speech Therapists
  • Recreational Therapists

Medical Treatment8

  • Baclofen - this is helpful in relieving muscle spasm. It is usually given orally but can be administered in the form of an intrathecal cannula and pump in cases of diffuse spasticity. This sometimes obviates the need for surgical intervention.
  • Dantrolene - this may work better than baclofen when muscle spasm is severe.
  • Diazepam - another option for severe muscle spasm.

Surgical Treatment8

A variety of surgical procedures may be helpful in certain situations, including:

  • Repair of scoliosis and hip dislocation.
  • Tendon lengthening or transfer to decrease the imbalance from muscle spasticity.
  • Osteotomy to realign a limb.
  • Selective posterior rhizotomy - this involves operating on nerve roots emanating from the spinal cord and is useful in selected patients with muscle spasticity. It is used less often now that the baclofen infusion pump is available.

Other Treatments8,5

  • Mobility aids - these may include orthotic devices, wheelchairs, and powered mobility walkers.18
  • Botulinus toxin - this can afford the relief of spasticity for 3-6 months.
  • Phenol injections - sometimes used in larger muscles, where botulinus would be ineffective.
  • Physical methods of spasticity relief include heat, cold and vibration.
  • Splinting can help to improve the range of movement of a joint; this can be particularly effective for ankle joints.

Other Issues

  • The psychological and physical health of carers should not be forgotten.
  • With improved care, the life expectancy of cerebral palsy patients is lengthening. The social and educational integration of young adults into the community is a matter of increasing importance.
Complications8
  • Contractions - the development of these can be minimised by effective treatment of spasticity.
  • Gastrointestinal symptoms - this includes reflux and oropharyngeal muscle disorders affecting swallowing and clearance of saliva. Failure to thrive and osteoporosis can result from nutritional deficiencies.
  • Pulmonary complications include aspiration pneumonia and bronchopulmonary dysplasia.
  • Dental problems can occur.
  • Mental retardation (in 30-50% of patients) is often associated with severe spastic quadriplegia.
  • Hearing loss - this is particularly seen where the secondary cause is hyperbilirubinaemia or exposure to ototoxic drugs.
Prognosis

Many patients with a mild form have a normal life expectancy. A two year old with mild palsy has a 99% chance of living to the age of 20, compared with a patient who has severe disease, where the figure can be as low as 40%.19A poor prognosis is associated with severe quadriplegia, epilepsy, mental retardation, and medical complications such as reflux and pulmonary disease.20
Studies suggest that if a child can sit up unaided at the age of 2 they will eventually be able to walk. If they are unable to sit by the age of 4, they will be unable to walk.20

Prevention5

Much has been done to reduce the incidence of cerebral palsy, including the recognition and treatment of maternal iodine deficiency, the prevention of kernicterus associated with rhesus isoimmunisation, and modern obstetric techniques to reduce birth trauma.5 Many cases of cerebral palsy are still unexplained, however, and further work needs to be done on the aetiology of perinatal brain injury.21


Document references
  1. Brainwave 2006; Cerebral Palsy
  2. Palisano R, Rosenbaum P, Walter S, et al; Development and reliability of a system to classify gross motor function in children with cerebral palsy.; Dev Med Child Neurol. 1997 Apr;39(4):214-23. [abstract]
  3. Palisano R; Gross Motor Function Classification System for Cerebral Palsy
  4. Surman G, Bonellie S, Chalmers J, et al; UKCP: a collaborative network of cerebral palsy registers in the United Kingdom.; J Public Health (Oxf). 2006 Jun;28(2):148-56. Epub 2006 Mar 23. [abstract]
  5. Rosenbaum P; Cerebral palsy: what parents and doctors want to know.; BMJ. 2003 May 3;326(7396):970-4.
  6. Wu YW, Croen LA, Shah SJ, et al; Cerebral palsy in a term population: risk factors and neuroimaging findings.; Pediatrics. 2006 Aug;118(2):690-7. [abstract]
  7. Cerebral Palsy - Thames Valley Children's Centre
  8. Thorogood C, Alexander MA, Cerebral Palsy (Physical Medicine and Rehabilitation) eMedicine (2005)
  9. Bushby K; Becker muscular dystrophy factsheet; Muscular Dystrophy Campaign
  10. Olezek J; Kugelberg Welander Spinal Muscular Atrophy eMedicine.com 2006
  11. Mitochondrial Cytopathies; The Cleveland Clinic Foundation
  12. Chuang DT, Chuang JL, Wynn RM; Lessons from genetic disorders of branched-chain amino acid metabolism.; J Nutr. 2006 Jan;136(1 Suppl):243S-9S. [abstract]
  13. Ancel PY, Livinec F, Larroque B, et al; Cerebral palsy among very preterm children in relation to gestational age and neonatal ultrasound abnormalities: the EPIPAGE cohort study.; Pediatrics. 2006 Mar;117(3):828-35. [abstract]
  14. Dyet LE, Kennea N, Counsell SJ, et al; Natural history of brain lesions in extremely preterm infants studied with serial magnetic resonance imaging from birth and neurodevelopmental assessment.; Pediatrics. 2006 Aug;118(2):536-48. [abstract]
  15. Zimmerman RA, Bilaniuk LT; Neuroimaging evaluation of cerebral palsy.; Clin Perinatol. 2006 Jun;33(2):517-44. [abstract]
  16. Leggatt A; Somatosensory Evoked Potentials: General Principles eMedicine.com 2006
  17. Bodensteiner JB, Johnsen SD; Magnetic resonance imaging (MRI) findings in children surviving extremely premature delivery and extremely low birthweight with cerebral palsy.; J Child Neurol. 2006 Sep;21(9):743-7. [abstract]
  18. Manley MT, Gurtowski J; The vertical wheeler: a device for ambulation in cerebral palsy.; Arch Phys Med Rehabil. 1985 Oct;66(10):717-20. [abstract]
  19. Hutton JL; Cerebral palsy life expectancy.; Clin Perinatol. 2006 Jun;33(2):545-55. [abstract]
  20. Ratanawongsa B, Cerebral Palsy. eMedicine (2005)
  21. du Plessis AJ, Volpe JJ; Perinatal brain injury in the preterm and term newborn.; Curr Opin Neurol. 2002 Apr;15(2):151-7. [abstract]

Internet and further reading Acknowledgements EMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 1657
Document Version: 21
DocRef: bgp24674
Last Updated: 3 Nov 2006
Review Date: 2 Nov 2008
Patient UK Current Health News
















Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>








Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page